• Rho CEO Laura Helms Reece Honored with Women in Business Award by the Triangle Business Journal

    Apr 14, 2015, 00:00 by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Apr 14, 2015 - Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, recently announced that Laura Helms Reece, Rho's co-chief executive officer, was recognized as a top businesswoman by the Triangle Business Journal,  a multimedia source for local business news, research and events in the Raleigh, Durham, Chapel Hill region of North Carolina, where Rho is headquartered
    Full story
  • New Book by Industry Thought Leaders Advocates for Re-Engineering Clinical Trials

    Apr 13, 2015, 00:00 by Michael Croft
    DUBLIN, IRELAND - Apr 13, 2015 - ICON plc (NASDAQ: ICLR), a global provider of drug and development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced the release of the book “Re-Engineering Clinical Trials” (ISBN: 9780124202467), edited and co-authored by Brendan Buckley, ICON’s Chief Medical Officer, and Peter Schüler, ICON’s SVP of Global Medical and Safety Services
    Full story
  • High Rate of Vendor Turnover in Test EHR Program for Meaningful Use

    Apr 9, 2015, 10:25 by Michael Croft
    Health Data Management | Epic and Cerner are the latest electronic health record providers to join the Designated Test EHR Program for hospitals attesting to their ability to share information with outside systems, as vendors have departed and been replaced.
    Full story
  • Intralinks and Wingspan Collaborate to Integrate

    Apr 8, 2015, 10:00 by Michael Croft
    Clinical Informatics News | Keeping certain documents under the control of the investigator is a basic tenet of clinical trials and built in to the new collaboration between Intralinks and Wingspan Technology. The purpose of the collaboration is to develop an integration between the Intralinks’ electronic investigator site file (eISF) and Wingspan’s electronic trial master file (eTMF).
    Full story
  • April News and Product Briefs

    Apr 3, 2015, 12:00 by Michael Croft
    Clinical Informatics News | News and product briefs from Medidata, QIAGEN, GoBalto, and more.
    Full story
  • Phase 0 Trials Test Drug Effects on Rare Tumors

    Apr 2, 2015, 11:00 by Michael Croft
    Clinical Informatics News | The Phoenix-based Translational Genomics Research Institute (TGen) and Barrow Neurological Institute at Dignity Health St. Joseph’s Hospital and Medical Center are undertaking innovative Phase 0 trials, incorporating drug candidates, surgery, and genomic sequencing to test new therapies to treat glioblastoma brain tumors.
    Full story
  • Certara Launches its Cardiac Safety Simulator V2.0

    Apr 2, 2015, 00:00 by Michael Croft
    PRINCETON, NJ - Apr 2, 2015 - Certara®, the global biosimulation technology-enabled consultancy, today announced the launch of version 2
    Full story
  • Estenda’s CDMP software makes significant differences in patients with type 2 diabetes

    Apr 1, 2015, 00:00 by Michael Croft
    CONSHOHOCKEN, PA, US - Apr 1, 2015 - Diabetes Care recently published an article called “An Internet Based Diabetes Management Platform Improves Team Care and Outcomes in an Urban Latino Population,” about a study that used Estenda’s digital health solution, the Comprehensive Diabetes Management Program (CDMP), to care for patients with type 2 diabetes (T2D)
    Full story
  • Cancer Groups Tap The Crowd To Boost Clinical Trial Participation

    Apr 1, 2015, 00:00 by Michael Croft
    Xconomy | Pushing a cancer therapy through clinical trials typically takes years and millions of dollars. But before trial organizers can even begin evaluating a drug's safety, they must first sign up patients to test it.
    Full story
  • The Complexities of Measuring Pain

    Mar 31, 2015, 10:35 by Michael Croft
    Wall Street Journal | As care providers and clinical trials alike rely more and more on patient-reported measurements of nebulous symptoms like pain, motivated patients are stepping up with suggestions.
    Full story
  • Personalized Medicine, Personal Choices

    Mar 27, 2015, 11:50 by Michael Croft
    Forbes | As genomic medicine continues to advance, patients will be faced with increasingly sensitive choices about their healthcare in the face of complex risk factors for serious diseases.
    Full story
  • Regulatory Considerations for Using Social and Digital Media in Clinical Trial Patient Recruitment

    Mar 26, 2015, 10:25 by Michael Croft
    Clinical Informatics News | Contributed Commentary | Social and digital media can be powerful tools for recruiting clinical trial participants and speeding up enrollment, but there are several regulatory as well as operational considerations to keep in mind.
    Full story
  • Interactive Online Map Shares Cancer Projects Around the World

    Mar 25, 2015, 17:00 by Michael Croft
    Clinical Informatics News | Global Oncology (GO) this morning announced the launch of the Global Cancer Project Map, a first-of-its-kind online resource and virtual information exchange for connecting the global cancer community. Developed by GO in collaboration with the National Cancer Institute (NCI) Center for Global Health, the map enables worldwide access to cancer projects and expertise to improve cancer practices and patient outcomes, especially in low-resource settings.
    Full story
  • PHT CORPORATION SPEEDS CLINICAL TRIAL TIMES WITH VODAFONE GLOBAL M2M TECHNOLOGY

    Mar 24, 2015, 00:00 by Michael Croft
    BOSTON, MA, UNITED STATES - Mar 24, 2015 - Vodafone and PHT Corporation, the leading provider of technologies used to collect electronic data for clinical research from patients, are working together to connect the PHT electronic clinical outcome assessment (eCOA) system to Vodafone's global M2M network
    Full story
  • A University’s Handling of Clinical Trial Practices Raises ‘Serious Ethical Issues’

    Mar 23, 2015, 00:00 by Michael Croft
    WSJ | University of Minnesota research practices stemming from the suicide of a clinical trial participant a decade ago raised serious issues that have damaged its "credibility and reputation."
    Full story
  • Capitation and Cognitive Dissonance: The Economics of Models of Care

    Mar 20, 2015, 10:00 by Michael Croft
    Clinical Informatics News | Eric Liederman, Director of Medical Informatics at Kaiser Permanente, has spent his career as both a physician and a clinical informatics systems director. He speaks with Clinical Informatics News about the economic differences between fee-for-service and capitated models of care and how cognitive dissonance changes the care patients receive. 
    Full story
  • Aaron Bernstein Appointed to International Group Updating ICH Guidelines on Clinical Study Protocols and Reports

    Mar 19, 2015, 00:00 by Michael Croft
    PRINCETON, NJ - Mar 19, 2015 - Certara®, the global biosimulation technology-enabled drug development and drug safety consulting company, today announced that Aaron Bernstein, Ph
    Full story
  • Clinical Ink, CentrosHealth Merger

    Mar 18, 2015, 16:00 by Michael Croft
    Clinical Informatis News Brief | Clinical Ink has merged with CentrosHealth, joining Clinical Ink’s eSource solutions with CentrosHealth’s mobile apps for clinical trial patient engagement and electronic patient reported outcomes (ePRO). The merger brings MPM Capital and F2 Ventures to Clinical Ink’s list of existing investors.
    Full story
  • Rho Showcases Clinical Services Expertise, Recruits New Employees at OCT Southeast

    Mar 17, 2015, 00:00 by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Mar 17, 2015 - WHAT:  Rho, a full-service contract research organization (CRO), will highlight its continued success in drug development strategies and services during the Outsourcing in Clinical Trials (OCT) Southeast conference, being held March 24-25 in Cary, North Carolina
    Full story
  • Certara Opens Larger Corporate Headquarters in Princeton, NJ(2)

    Mar 17, 2015, 00:00 by Michael Croft
    PRINCETON, NJ - Mar 17, 2015 - Certara®, the global biosimulation technology-enabled drug development and drug safety consulting company, today announced that as a result of its rapid growth, the company is moving its corporate headquarters to a larger location in Princeton, NJ
    Full story